ORLANDO – A topical corticosteroid spray quickly and effectively reduced scaling in patients with plaque psoriasis, according to pooled phase III st... More »
New studies have led to a number of newly approved medications and therapies for patients suffering from psoriasis and psoriatic arthritis, and severa... More »
An updated version of a blood screening assay that detects human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus... More »
More than half of reproductive-age women who are eligible for tax credits through the Affordable Care Act marketplaces can’t buy a health plan that ... More »
SILVER SPRING, MD. – A novel treatment for invasive aspergillosis and invasive mucormycosis gained the support of a Food and Drug Administration adv... More »
Measuring proteinuria 12 months into a clinical trial is the best way to predict long-term renal outcomes in lupus nephritis patients, according to re... More »
The future looks bright for new atopic dermatitis treatments, according to Dr. Charles Ellis, a dermatology professor at the University of Michigan in Ann Arbor.
“I think we are at the point where...
Nearly 40% of a reproductive age women enrolled in Medicaid and nearly 30% of those with private insurance filled an opioid prescription between 2008 ... More »
The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults.
The injectable interleukin-17A inhibitor is indicated for...
SAN ANTONIO – Adjuvant aromatase inhibitor therapy in postmenopausal breast cancer survivors was associated with an increased risk of incident nonis... More »